Received 5 May 2013
aDepartment of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium,bDepartment of Organic Chemistry, Baku State University, Baku, Azerbaijan,cDepartment of Chemistry, University of Antwerp, Antwerp, Belgium,dDepartment of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran, and eDeutsches Elektronen-Synchrotron (DESY), Division Structural Dynamics of (Bio)chemical Systems, Notkestrasse 85, 22607 Hamburg, Germany
Correspondence e-mail: email@example.com
In the title compound, [Ni(C8H14N6S2)], the NiII ion is coordinated by N2S2 donor atoms of the tetradentate thiosemicarbazone ligand, and has a slightly distorted square-planar geometry. In the crystal, inversion-related molecules are linked via pairs of N-HN and N-HS hydrogen bonds, forming R22(8) ring motifs. Molecules are further linked by slightly weaker N-HN, N-HS and C-HS hydrogen bonds, forming two-dimensional networks which lie parallel to the bc plane.
For standard values of bond lengths, see: Allen et al. (1987). For hydrogen-bond motifs, see: Bernstein et al. (1995). For related structures, see: Cowley et al. (2004); Lobana et al. (2011). The antitumor and antibacterial activity of thiosemicarbazones and thiosemicarbazides has been attributed to their ability to chelate trace metals, see: Kirschner et al. (1966). For the preparation of hexan-2,5-dionebis(thiosemicarbazone), see: Nandi et al. (1984).
Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT-Plus (Bruker, 2005); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SU2598 ).
The authors thank the Chemistry Department of BSU for providing the X-ray diffraction facility.
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
Bruker (2005). APEX2, SAINT-Plus and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cowley, A. R., Dilworth, J. R., Donnelly, P. S., Gee, A. D. & Heslop, J. M. (2004). Dalton Trans. pp. 2404-2412.
Kirschner, S., Weu, Y. K., Francis, D. & Bergman, J. G. (1966). J. Med. Chem. 9, 369-375.
Lobana, T. S., Kumari, P., Sharma, R., Castineiras, A., Butcher, R. J., Akitsu, T. & Aritake, Y. (2011). Dalton Trans. pp. 3219-3228.
Nandi, A. K., Chaudhuri, S. & Mazumdar, S. K. (1984). Inorg. Chim. Acta, 92, 235-240.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Spek, A. L. (2009). Acta Cryst. D65, 148-155.